Clinical Trial

The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 2, 2025 (before its estimated October 29, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blind, placebo-controlled, single-center Phase IIa clinical study.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-04; most recent amendment 2025-08-25.
Status change: Not Yet Recruiting → Recruiting 2025-07-21
Trial Details
NCT Number NCT07057414
Lead Sponsor Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.
Collaborators: Guangdong Provincial Hospital for Occupational Disease Prevention and Treatment
Conditions Cadmium Exceeds the Standard
Enrollment 11 participants
Start Date 2025-07-07
Primary Completion 2025-10-29 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-02